Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LORMETAZEPAM Cause Toxicity to various agents? 315 Reports in FDA Database

Wake Up Pain-Free — Sleep Like Never Before

Derila Ergo Pillow: ergonomic design, cooling tech. 75% OFF today.

Shop Now — 75% Off

According to the FDA Adverse Event Reporting System (FAERS), 315 reports of Toxicity to various agents have been filed in association with LORMETAZEPAM. This represents 10.3% of all adverse event reports for LORMETAZEPAM.

315
Reports of Toxicity to various agents with LORMETAZEPAM
10.3%
of all LORMETAZEPAM reports
96
Deaths
188
Hospitalizations

How Dangerous Is Toxicity to various agents From LORMETAZEPAM?

Of the 315 reports, 96 (30.5%) resulted in death, 188 (59.7%) required hospitalization, and 96 (30.5%) were considered life-threatening.

Is Toxicity to various agents Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LORMETAZEPAM. However, 315 reports have been filed with the FAERS database.

What Other Side Effects Does LORMETAZEPAM Cause?

Drug abuse (488) Coma (426) Somnolence (310) Fall (246) Poisoning deliberate (218) Intentional overdose (187) Drug dependence (181) Overdose (157) Suicide attempt (150) Sopor (149)

What Other Drugs Cause Toxicity to various agents?

OXYCODONE (17,518) ACETAMINOPHEN (16,128) FENTANYL (15,546) MORPHINE (15,337) BUPRENORPHINE (10,906) HYDROMORPHONE (10,769) HYDROCODONE (10,645) ACETAMINOPHEN\OXYCODONE (10,568) ACETAMINOPHEN\HYDROCODONE (10,343) TAPENTADOL (9,617)

Which LORMETAZEPAM Alternatives Have Lower Toxicity to various agents Risk?

LORMETAZEPAM vs LORNOXICAM LORMETAZEPAM vs LOSARTAN LORMETAZEPAM vs LOSARTAN\LOSARTAN LORMETAZEPAM vs LOTEPREDNOL ETABONATE LORMETAZEPAM vs LOTEPREDNOL ETABONATE\TOBRAMYCIN

Related Pages

LORMETAZEPAM Full Profile All Toxicity to various agents Reports All Drugs Causing Toxicity to various agents LORMETAZEPAM Demographics